Insider Selling: Gevo CEO Sells 7,309 Shares of Stock (GEVO)
Gevo (NASDAQ:GEVO) CEO Patrick R. Gruber sold 7,309 shares of Gevo stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $0.96, for a total transaction of $7,016.64. Following the completion of the sale, the chief executive officer now directly owns 378,072 shares in the company, valued at approximately $362,949. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Gevo (NASDAQ:GEVO) traded down 0.93% on Thursday, hitting $0.9114. The stock had a trading volume of 173,630 shares. Gevo has a 52-week low of $0.73 and a 52-week high of $2.30. The stock has a 50-day moving average of $0.94 and a 200-day moving average of $1.20. The company’s market cap is $61.8 million.
Gevo (NASDAQ:GEVO) last announced its earnings results on Wednesday, May 14th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.03. The company had revenue of $0.90 million for the quarter, compared to the consensus estimate of $1.70 million. During the same quarter in the previous year, the company posted ($0.45) earnings per share. The company’s revenue for the quarter was down 74.3% on a year-over-year basis. On average, analysts predict that Gevo will post $-0.67 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on GEVO shares. Analysts at Cowen and Company cut their price target on shares of Gevo to $1.00 in a research note on Friday, May 16th. Separately, analysts at Zacks downgraded shares of Gevo from an “outperform” rating to a “neutral” rating in a research note on Thursday, May 8th. They now have a $1.30 price target on the stock. Finally, analysts at Zacks upgraded shares of Gevo from a “neutral” rating to an “outperform” rating in a research note on Wednesday, April 9th. They now have a $1.50 price target on the stock.
Gevo, Inc, is a renewable chemicals and advanced biofuels company. The Company is focused on the development and commercialization of alternatives to petroleum-based products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.